Gerrit Reepmeyer – författare
Visar alla böcker från författaren Gerrit Reepmeyer. Handla med fri frakt och snabb leverans.
11 produkter
UnCommoditized
Uncommon Ideas for Commoditized Markets
Av Saikat Dey, Gerrit Reepmeyer
Inbunden, 2015
345 kr
Lägg i varukorg
Leading Pharmaceutical Innovation
How to Win the Life Science Race
Av Oliver Gassmann, Alexander Schuhmacher m. fl.
Häftad, 2019
646 kr
Lägg i varukorg
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management …
Führung und Organisation pharmazeutischer Innovation
Wie man den Wettlauf der Life Sciences gewinnt
Av Oliver Gassmann, Alexander Schuhmacher m. fl.
Inbunden, 2024
480 kr
Lägg i varukorg
Dieses Buch untersucht und beleuchtet die wichtigsten Herausforderungen, denen sich die pharmazeutische Industrie in einem zunehmend wettbewerbsorientierten Umfeld mit inflationären F&E-Investitionen und verschärftem Kostendruck stellen muss. Die Autoren stellen drei Quellen der pharmazeutischen …
Führung und Organisation pharmazeutischer Innovation
Wie man den Wettlauf der Life Sciences gewinnt
Av Gerrit Reepmeyer, Max von Zedtwitz m. fl.
E-bok, 2024
504 kr
Lägg i varukorg
Dieses Buch untersucht und beleuchtet die wichtigsten Herausforderungen, denen sich die pharmazeutische Industrie in einem zunehmend wettbewerbsorientierten Umfeld mit inflationären F&E-Investitionen und verschärftem Kostendruck stellen muss. Die Autoren stellen drei Quellen der pharmazeutischen …
Leading Pharmaceutical Innovation
How to Win the Life Science Race
Av Oliver Gassmann, Alexander Schuhmacher m. fl.
Inbunden, 2018
878 kr
Lägg i varukorg
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management …
Leading Pharmaceutical Innovation
How to Win the Life Science Race
Av Gerrit Reepmeyer, Max von Zedtwitz m. fl.
E-bok, 2018
813 kr
Lägg i varukorg
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management …
Leading Pharmaceutical Innovation
Trends and Drivers for Growth in the Pharmaceutical Industry
Av Maximilian von Zedtwitz, Gerrit Reepmeyer m. fl.
E-bok, 2013
1209 kr
Lägg i varukorg
Pharmaceutical innovation is like gambling at roulette, only the stakes are higher. Considerably higher, since the most recent estimates put the costs of drug development at US$ 800 million to US$ 1 billion - per drug! This is equivalent to the price tag of the Empire State Building, when it was …
Leading Pharmaceutical Innovation
Trends and Drivers for Growth in the Pharmaceutical Industry
Av Maximilian von Zedtwitz, Gerrit Reepmeyer m. fl.
E-bok, 2008
755 kr
Lägg i varukorg
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business …
Risk-sharing in the Pharmaceutical Industry
The Case of Out-licensing
Häftad, 2005
1130 kr
Lägg i varukorg
The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from …
Risk-sharing in the Pharmaceutical Industry
The Case of Out-licensing
E-bok, 2006
1470 kr
Lägg i varukorg
The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from …
Leading Pharmaceutical Innovation
Trends and Drivers for Growth in the Pharmaceutical Industry
Av Oliver Gassmann, Gerrit Reepmeyer m. fl.
Inbunden, 2008
770 kr
Tillfälligt slut
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business …
